Jakko A Nieuwenhuijzen
Overview
Explore the profile of Jakko A Nieuwenhuijzen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berrens A, Buckle T, van Oosterom M, Slof L, van Leeuwen P, Wit E, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):2250.
PMID: 39673025
No abstract available.
2.
Berrens A, Buckle T, van Oosterom M, Slof L, van Leeuwen P, Wit E, et al.
Ann Surg Oncol
. 2024 Dec;
32(2):1389-1390.
PMID: 39663324
No abstract available.
3.
Beijert I, Wever B, Hentschel A, van den Burgt Y, Kauer P, Lissenberg-Witte B, et al.
Sci Rep
. 2024 Nov;
14(1):28705.
PMID: 39567591
Although cystoscopy is a reliable tool for detecting bladder cancer (BC) in patients with hematuria, it is invasive, costly and often unnecessary since most patients with hematuria do not have...
4.
Berrens A, Buckle T, van Oosterom M, Slof L, van Leeuwen P, Wit E, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1372-1381.
PMID: 39562421
Background: The invasive nature of extended pelvic lymph node dissection (ePLND) prompts the need for alternative lymphatic mapping technologies. To change the focus to "sparing nodes that are not involved,"...
5.
Celli L, Garrelfs M, Sakkers R, Elting M, Celli M, Bokenkamp A, et al.
Calcif Tissue Int
. 2024 Nov;
115(6):960-975.
PMID: 39535563
Osteogenesis Imperfecta (OI), known as "brittle bone disease," presents a rare genetic disorder characterized by bone fragility, often accompanied by skeletal deformities and extraskeletal complications. OI is primarily associated with...
6.
van Altena E, Jansen B, Korbee M, Knol R, Luining W, Nieuwenhuijzen J, et al.
Eur Urol Oncol
. 2024 Oct;
PMID: 39414419
Background And Objective: Biochemical recurrence (BCR) of prostate cancer (PCa) after curative radiotherapy (RT) is defined according to the Phoenix criteria, which is a prostate-specific antigen (PSA) rise of ≥2.0 ...
7.
de Ruiter R, Botman E, Teunissen B, Lammertsma A, Boellaard R, Raijmakers P, et al.
Front Nucl Med
. 2024 Oct;
4:1406947.
PMID: 39381032
Background: Fibrodysplasia Ossificans Progressiva (FOP) is a rare, genetic disease in which heterotopic bone is formed in muscles, tendons and ligaments throughout the body. Disease progression is variable over time...
8.
Aguilera Saiz L, Heerink W, Groen H, Hiep M, van der Poel H, Wit E, et al.
Eur Urol
. 2024 Aug;
PMID: 39174413
Background And Objective: Image-guided surgical navigation (IGSN) can enhance surgical precision and safety. The expansion of minimally invasive surgery has increased the demand for integration of these navigation systems into...
9.
Remmelink M, Rip Y, Nieuwenhuijzen J, Ket J, Oddens J, de Reijke T, et al.
BJU Int
. 2024 Jul;
134(6):890-905.
PMID: 39015996
Objectives: To systematically assess the current available literature concerning advanced optical imaging methods for the detection and diagnosis of bladder cancer (BCa), focusing particularly on the sensitivity and specificity of...
10.
van der Graaf S, Hagens M, Veerman H, Roeleveld T, Nieuwenhuijzen J, Wit E, et al.
Eur Urol Focus
. 2024 Apr;
10(5):754-760.
PMID: 38631992
Background And Objective: The implementation of quality assurance programs (QAPs) within urological practice has gained prominence; yet, their impact on outcomes after radical prostatectomy (RP) remains uncertain. This paper aims...